Role of Epithelial Barrier Integrity in Biologic Treatment Response of Severe Asthmatics With/Out Chronic Rhinosinusitis With Nasal Polyps (CRSwNP).

RecruitingOBSERVATIONAL

Enrollment

Participants

Timeline

Start Date

May 15, 2022

Primary Completion Date

May 15, 2025

Study Completion Date

November 16, 2025

Conditions

Severe Eosinophilic Asthma w/wo CRSwNP

Interventions

DRUG

Mepolizumab 100 MG

Patients with SEA eligible to receive anti-IL5 treatment, which is a biologic treatment for SEA

Trial Locations (2)

ACTIVE_NOT_RECRUITING

"PAGNI University Hospital, Crete", Heraklion

RECRUITING

Aikaterini Antoniou, Heraklion

All Listed Sponsors

lead

University of Crete

OTHER